Merit Medical® 00884450403983Recalls & reported problems
Merit Medical Systems, Inc. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00884450403983), received between Jul 27, 2022 and Jul 27, 2022 — classified as 3 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Memory Loss/Impairment2
- Muscle Weakness/Atrophy2
- Speech Disorder1
- Visual Impairment1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryJul 27, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE ACCOUNT ALLEGES THAT A PATIENT WAS ADMITTED FOR CAD. POST LHC PROCEDURE THE PATIENT WAS EVALUATED IN RECOVERY UNIT. THE PATIENT EXPERIENCED EXPRESSIVE APHASIA AND WAS POSITIVELY DIAGNOSED WITH AN EMBOLIC STROKE. THE PATIENT WAS TREATED AND DISCHARGED TO HOME WITH CONTINUED IMPAIRMENT AND SLIGHT EXPRESSIVE APHASIA.
Patient problems: Memory Loss/Impairment; Speech Disorder
MAUDE report 15115093 ↗InjuryJul 27, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE ACCOUNT ALLEGES THAT A PATIENT WAS EVALUATED AND TREATED FOR CAD AND AORTIC VALVE STENOSIS. POST RHC AND LHC PROCEDURE, DURING RECOVERY IN THE UNIT, THE PATIENT ALLEGED TO HAVE SLIGHT MEMORY LOSS AND ARM WEAKNESS AND WAS POSITIVELY DIAGNOSED WITH AN EMBOLIC STROKE. THE PATIENT WAS SUCCESSFULLY TREATED AND DISCHARGED TO HOME WITH SLIGHT MEMORY LOSS AND LEFT ARM WEAKNESS.
Patient problems: Memory Loss/Impairment; Muscle Weakness/Atrophy
MAUDE report 15115051 ↗InjuryJul 27, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE ACCOUNT ALLEGES THAT THE PATIENT WAS EVALUATED AND TREATED FOR CAD. POST PCI PROCEDURE, THE PATIENT COMPLAINED OF LEFT ARM WEAKNESS AND WAS POSITIVELY DIAGNOSED WITH AN EMBOLIC STROKE IN RECOVERY UNIT. THE PATIENT WAS SUCCESSFULLY TREATED AND DISCHARGED TO HOME WITH LOSS OF PERIPHERAL VISION AND WEAKNESS IN THE ARM.
Patient problems: Muscle Weakness/Atrophy; Visual Impairment
MAUDE report 15115009 ↗
Other Cardiovascular procedure kit devices
- Medline Industries, Inc. CDS840396YMedline Industries, Inc. · Cardiovascular procedure kit6 recalls0 reports
- Medline Industries, Inc. CDS983513FMedline Industries, Inc. · Cardiovascular procedure kit6 recalls0 reports
- Medline Industries, Inc. CDS840396XMedline Industries, Inc. · Cardiovascular procedure kit5 recalls0 reports
- Medline Industries, Inc. CDS984355GMedline Industries, Inc. · Cardiovascular procedure kit5 recalls0 reports
- Medline Industries, Inc. DYNJ51038RMedline Industries, Inc. · Cardiovascular procedure kit4 recalls2 reports
- NAMIC 60033123Medline Industries, Inc. · Cardiovascular procedure kit4 recalls0 reports
- Medline Industries, Inc. DYNJ905079FMedline Industries, Inc. · Cardiovascular procedure kit4 recalls0 reports
- Medline Industries, Inc. DYNJ0376608OMedline Industries, Inc. · Cardiovascular procedure kit4 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page